Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 O Hamid, C Robert, A Daud, FS Hodi, WJ Hwu, R Kefford, JD Wolchok, ... Annals of Oncology 30 (4), 582-588, 2019 | 779 | 2019 |
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma AC Huang, RJ Orlowski, X Xu, R Mick, SM George, PK Yan, S Manne, ... Nature medicine 25 (3), 454-461, 2019 | 542 | 2019 |
Strategies for dealing with missing data in clinical trials: from design to analysis JD Dziura, LA Post, Q Zhao, Z Fu, P Peduzzi The Yale journal of biology and medicine 86 (3), 343, 2013 | 394 | 2013 |
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma A Ribas, D Lawrence, V Atkinson, S Agarwal, WH Miller Jr, MS Carlino, ... Nature medicine 25 (6), 936-940, 2019 | 305 | 2019 |
Combining multidimensional genomic measurements for predicting cancer prognosis: observations from TCGA Q Zhao, X Shi, Y Xie, J Huang, BC Shia, S Ma Briefings in bioinformatics 16 (2), 291-303, 2015 | 145 | 2015 |
Phase Ib/II study of pembrolizumab and pegylated-interferon alfa-2b in advanced melanoma D Davar, H Wang, JM Chauvin, O Pagliano, JJ Fourcade, M Ka, C Menna, ... Journal of Clinical Oncology 36 (35), 3450, 2018 | 66 | 2018 |
Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis Y Jiang, X Shi, Q Zhao, M Krauthammer, BEG Rothberg, S Ma Genomics 107 (6), 223-230, 2016 | 55 | 2016 |
Integrative analysis of ‘‐omics’ data using penalty functions Q Zhao, X Shi, J Huang, J Liu, Y Li, S Ma Wiley Interdisciplinary Reviews: Computational Statistics 7 (1), 99-108, 2015 | 40 | 2015 |
Transcriptomic determinants of response to pembrolizumab monotherapy across solid tumor types R Cristescu, M Nebozhyn, C Zhang, A Albright, J Kobie, L Huang, Q Zhao, ... Clinical Cancer Research 28 (8), 1680-1689, 2022 | 37 | 2022 |
Integrating multidimensional omics data for cancer outcome R Zhu, Q Zhao, H Zhao, S Ma Biostatistics 17 (4), 605-618, 2016 | 36 | 2016 |
Deciphering the associations between gene expression and copy number alteration using a sparse double Laplacian shrinkage approach X Shi, Q Zhao, J Huang, Y Xie, S Ma Bioinformatics (2015), btv518, 2015 | 32 | 2015 |
Tumor mutational burden (TMB), T cell-inflamed gene expression profile (GEP) and PD-L1 are independently associated with response to pembrolizumab (Pembro) in patients with … A Ribas, C Robert, J Schachter, GV Long, A Arance, MS Carlino, J Larkin, ... Cancer Research 79 (13_Supplement), 4217-4217, 2019 | 18 | 2019 |
Analysis of cancer gene expression data with an assisted robust marker identification approach H Chai, X Shi, Q Zhang, Q Zhao, Y Huang, S Ma Genetic epidemiology 41 (8), 779-789, 2017 | 17 | 2017 |
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study IM Shui, XQ Liu, Q Zhao, ST Kim, Y Sun, JH Yearley, T Choudhury, ... Journal for Immunotherapy of Cancer 10 (7), 2022 | 14 | 2022 |
Inferring gene regulatory relationships with a high‐dimensional robust approach Y Zang, Q Zhao, Q Zhang, Y Li, S Zhang, S Ma Genetic epidemiology 41 (5), 437-454, 2017 | 13 | 2017 |
Association of gene expression with clinical outcomes in patients with renal cell carcinoma treated with pembrolizumab in KEYNOTE-427. DF McDermott, JL Lee, F Donskov, SS Tykodi, GA Bjarnason, JMG Larkin, ... Journal of Clinical Oncology 38 (15_suppl), 5024-5024, 2020 | 9 | 2020 |
The effects of house dust mite sublingual immunotherapy tablet on immunologic biomarkers and nasal allergen challenge symptoms NC Gunawardana, Q Zhao, LN Carayannopoulos, K Tsai, VA Malkov, ... Journal of Allergy and Clinical Immunology 141 (2), 785-788. e9, 2018 | 9 | 2018 |
Pan-tumor analysis of the association of cancer and immune biology-related gene expression signatures with response to pembrolizumab monotherapy R Cristescu, M Nebozhyn, C Zhang, A Albright, J Kobie, L Huang, Q Zhao, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 4 | 2019 |
Differential transcriptomic profiling in ibrutinib-naïve versus ibrutinib-resistant Richter syndrome H Wang, S Tian, Q Zhao, W Blumenschein, JH Yearley, CR Secreto, ... Hematological oncology 40 (2), 302-306, 2022 | 1 | 2022 |
Distinct Gene Expression Signatures in Patients with Richter's Syndrome and Chronic Lymphocytic Leukemia with Prior Exposure to Ibrutinib H Wang, S Tian, Q Zhao, W Blumenschein, JH Yearley, CR Secreto, ... Blood 136, 30-31, 2020 | 1 | 2020 |